JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A1778 Vatalanib (PTK787) 2HCl

Target: VEGFR

Summary: Tyrosine kinase receptor inhibitor

≥21 mg/mL
A8393 CH5424802

Target: ALK

Summary: ALK inhibitor,potent and ATP-competitive
B2284 Fostamatinib (R788)

Target: Syk

Summary: Spleen tyrosine kinase (Syk) inhibitor

insoluble in H2O; ≥100.4 mg/mL
B5859 Entrectinib

Target: Trk Receptors|ALK|ROS1

Summary: Orally active inhibitor of ALK kinase

≥28.05 mg/mL
A3573 LY2801653

Target: MET

Summary: MET inhibitor

≥27.65 mg/mL